1. Home
  2. VERV vs HPP Comparison

VERV vs HPP Comparison

Compare VERV & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • HPP
  • Stock Information
  • Founded
  • VERV 2018
  • HPP 2009
  • Country
  • VERV United States
  • HPP United States
  • Employees
  • VERV N/A
  • HPP N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • HPP Real Estate
  • Sector
  • VERV Health Care
  • HPP Finance
  • Exchange
  • VERV Nasdaq
  • HPP Nasdaq
  • Market Cap
  • VERV 475.0M
  • HPP 420.6M
  • IPO Year
  • VERV 2021
  • HPP 2010
  • Fundamental
  • Price
  • VERV $6.14
  • HPP $3.14
  • Analyst Decision
  • VERV Strong Buy
  • HPP Hold
  • Analyst Count
  • VERV 4
  • HPP 11
  • Target Price
  • VERV $25.75
  • HPP $4.75
  • AVG Volume (30 Days)
  • VERV 1.5M
  • HPP 6.1M
  • Earning Date
  • VERV 02-25-2025
  • HPP 02-20-2025
  • Dividend Yield
  • VERV N/A
  • HPP 3.19%
  • EPS Growth
  • VERV N/A
  • HPP N/A
  • EPS
  • VERV N/A
  • HPP N/A
  • Revenue
  • VERV $24,396,000.00
  • HPP $847,713,000.00
  • Revenue This Year
  • VERV $97.47
  • HPP N/A
  • Revenue Next Year
  • VERV N/A
  • HPP N/A
  • P/E Ratio
  • VERV N/A
  • HPP N/A
  • Revenue Growth
  • VERV 219.91
  • HPP N/A
  • 52 Week Low
  • VERV $4.31
  • HPP $2.39
  • 52 Week High
  • VERV $19.34
  • HPP $9.25
  • Technical
  • Relative Strength Index (RSI)
  • VERV 53.75
  • HPP 53.31
  • Support Level
  • VERV $5.32
  • HPP $2.84
  • Resistance Level
  • VERV $6.87
  • HPP $3.04
  • Average True Range (ATR)
  • VERV 0.52
  • HPP 0.17
  • MACD
  • VERV -0.00
  • HPP 0.06
  • Stochastic Oscillator
  • VERV 56.74
  • HPP 94.75

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: